LLY
Price
$1003.46
Change
+$148.11 (+17.32%)
Updated
Feb 3 closing price
Capitalization
898.12B
Earnings call today
Intraday BUY SELL Signals
OGN
Price
$8.00
Change
-$1.92 (-19.35%)
Updated
Feb 3 closing price
Capitalization
2.08B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LLY vs OGN

Header iconLLY vs OGN Comparison
Open Charts LLY vs OGNBanner chart's image
Eli Lilly & Co
Price$1003.46
Change+$148.11 (+17.32%)
Volume$5.48M
Capitalization898.12B
Organon & Co
Price$8.00
Change-$1.92 (-19.35%)
Volume$4.57M
Capitalization2.08B
LLY vs OGN Comparison Chart in %
LLY
Daily Signal:
Gain/Loss:
OGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LLY vs. OGN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Hold and OGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LLY: $1003.46 vs. OGN: $8.00)
Brand notoriety: LLY: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 181% vs. OGN: 82%
Market capitalization -- LLY: $898.12B vs. OGN: $2.08B
LLY [@Pharmaceuticals: Major] is valued at $898.12B. OGN’s [@Pharmaceuticals: Major] market capitalization is $2.08B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $898.12B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $114.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 3 green FA rating(s).

  • LLY’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 3 green, 2 red.
According to our system of comparison, OGN is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).

  • LLY’s TA Score: 4 bullish, 4 bearish.
  • OGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LLY is a better buy in the short-term than OGN.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а -3.47% price change this week, while OGN (@Pharmaceuticals: Major) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.82%. For the same industry, the average monthly price growth was +4.65%, and the average quarterly price growth was +18.14%.

Reported Earning Dates

LLY is expected to report earnings on Feb 04, 2026.

OGN is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+1.82% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($898B) has a higher market cap than OGN($2.08B). LLY has higher P/E ratio than OGN: LLY (49.17) vs OGN (4.19). OGN YTD gains are higher at: 11.576 vs. LLY (-6.627). LLY has higher annual earnings (EBITDA): 25.3B vs. OGN (1.56B). LLY has more cash in the bank: 9.91B vs. OGN (672M). OGN has less debt than LLY: OGN (8.83B) vs LLY (42.5B). LLY has higher revenues than OGN: LLY (59.4B) vs OGN (6.3B).
LLYOGNLLY / OGN
Capitalization898B2.08B43,173%
EBITDA25.3B1.56B1,623%
Gain YTD-6.62711.576-57%
P/E Ratio49.174.191,174%
Revenue59.4B6.3B943%
Total Cash9.91B672M1,475%
Total Debt42.5B8.83B481%
FUNDAMENTALS RATINGS
LLY: Fundamental Ratings
LLY
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
8

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LLYOGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 13 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
52%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
LLY
Daily Signal:
Gain/Loss:
OGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPDN9.390.08
+0.86%
Direxion Daily S&P 500® Bear 1X ETF
FTBD49.580.03
+0.06%
Fidelity Tactical Bond ETF
FYC100.76-0.33
-0.33%
First Trust Small Cap Gr AlphaDEX® ETF
SPY689.53-5.88
-0.85%
State Street® SPDR® S&P 500® ETF
BITW50.29-1.06
-2.06%
Bitwise 10 Crypto Index ETF

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-3.90%
AZN - LLY
44%
Loosely correlated
-2.17%
ABBV - LLY
39%
Loosely correlated
+0.01%
MRK - LLY
38%
Loosely correlated
+2.18%
PFE - LLY
38%
Loosely correlated
-3.34%
OGN - LLY
34%
Loosely correlated
-2.44%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-2.44%
BIIB - OGN
39%
Loosely correlated
-1.30%
GSK - OGN
39%
Loosely correlated
+1.66%
AZN - OGN
37%
Loosely correlated
-2.17%
SNY - OGN
36%
Loosely correlated
+0.47%
LLY - OGN
35%
Loosely correlated
-3.90%
More